Log in to save to my catalogue

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosth...

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosth...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_387295

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

About this item

Full title

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

Publisher

New York: Wiley Periodicals, Inc

Journal title

Clinical cardiology (Mahwah, N.J.), 2019-05, Vol.42 (5), p.568-571

Language

English

Formats

Publication information

Publisher

New York: Wiley Periodicals, Inc

More information

Scope and Contents

Contents

Background
The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain.
Hypothesis
We evaluated the safety and efficacy of apixaban vs warfarin in patients with AF and a history of BPV replacement or native valve repair.
Methods
Usi...

Alternative Titles

Full title

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_387295

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_387295

Other Identifiers

ISSN

0160-9289,1932-8737

E-ISSN

1932-8737

DOI

10.1002/clc.23178

How to access this item